Deltanoid’s and Abbott’s Renal Partnership
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 51 (Table of Contents)
Published: 4 Sep-2004
DOI: 10.3833/pdr.v2004.i51.780 ISSN: 1756-7874
Section: General
Abstract
Abbott Laboratories and Deltanoid Pharmaceuticals entered into an option and licence agreement to develop novel Vitamin D Receptor Activators (VDRAs) for treating chronic kidney disease...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
Last Issue PDF
RSS